{
  "id": "167bee4828d09e25",
  "title": "uniQure Provides Regulatory Update on AMT-130 for Huntington\u2019s Disease",
  "description": "LEXINGTON, Mass. and AMSTERDAM, Dec. 04, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the company received final meeting mi\u2026",
  "content": "LEXINGTON, Mass. and AMSTERDAM, Dec. 04, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs\u2026 [+5266 chars]",
  "source": "GlobeNewswire",
  "source_url": "https://www.globenewswire.com/news-release/2025/12/04/3199658/0/en/uniQure-Provides-Regulatory-Update-on-AMT-130-for-Huntington-s-Disease.html",
  "published_at": "2025-12-04T12:05:00Z",
  "fetched_at": "2025-12-06T18:33:06.472112+00:00",
  "category": "politics_governance",
  "subcategory": null,
  "keywords": [
    "regulatory",
    "gene therapy",
    "search:drug approval FDA breakthrough"
  ],
  "location": null,
  "raw_data": {
    "source": {
      "id": null,
      "name": "GlobeNewswire"
    },
    "author": "uniQure Inc.",
    "title": "uniQure Provides Regulatory Update on AMT-130 for Huntington\u2019s Disease",
    "description": "LEXINGTON, Mass. and AMSTERDAM, Dec. 04, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the company received final meeting mi\u2026",
    "url": "https://www.globenewswire.com/news-release/2025/12/04/3199658/0/en/uniQure-Provides-Regulatory-Update-on-AMT-130-for-Huntington-s-Disease.html",
    "urlToImage": "https://ml.globenewswire.com/Resource/Download/2ba61fe2-12e5-4a01-afe1-419652b31512",
    "publishedAt": "2025-12-04T12:05:00Z",
    "content": "LEXINGTON, Mass. and AMSTERDAM, Dec. 04, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs\u2026 [+5266 chars]"
  }
}